FDA NDC Directory · JSON-LD · Markdown

Praluent

NDC 0024-5902 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namealirocumab
Labeler / ManufacturerSanofi-Aventis U.S. LLC
Marketing categoryBiologic License Application · App BLA125559
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsALIROCUMAB (150 mg/mL)
Marketing started20150724
Package count2

External sources

Source: openFDA. Public-domain (CC0).